The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study
Abstract Background Tuberculosis is a major global public health concern. Patients with tuberculosis who require critical care have a high mortality and delay in initiating antituberculous therapy is associated with increased mortality. Lipoarabinomannan (LAM) is a lipopolysaccharide found in the ce...
Main Authors: | Kim de Vasconcellos, Praksha Ramjathan, Dhivendra Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-05979-y |
Similar Items
-
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
by: Julio Flores, et al.
Published: (2021-04-01) -
Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
by: Margarida Correia-Neves, et al.
Published: (2019-09-01) -
Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of pulmonary tuberculosis in HIV patients: Egyptian experience
by: Nagwa Elhalawany, et al.
Published: (2021-04-01) -
Diagnostic accuracy of Lipoarabinomannan detection by lateral flow assay in pleural tuberculosis
by: Atish Mohapatra, et al.
Published: (2024-02-01) -
A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
by: Chakrapani Chatla, et al.
Published: (2021-01-01)